Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.045
-0.003-6.25%
Volume:11.01M
Turnover:511.21K
Market Cap:99.81M
PE:-0.97
High:0.048
Open:0.048
Low:0.045
Close:0.048
52wk High:0.485
52wk Low:0.045
Shares:2.22B
Float Shares:1.72B
Volume Ratio:0.81
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.046
EPS(LYR):-0.047
ROE:-121.11%
ROA:-53.38%
PB:1.85
PE(LYR):-0.96

Loading ...

Company Profile

Company Name:
BOTANIX PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
1984
Employees:
11
Office Location:
41-47 Colin Street,Suite 3,West Perth,Western Australia,Australia
Zip Code:
6005
Fax:
61 8 6210 1153
Introduction:
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.